These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14642500)

  • 21. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated volumetric determination of high R
    Tessema AW; Lee H; Gong Y; Cho H; Adem HM; Lyu I; Lee JH; Cho H
    NMR Biomed; 2022 Nov; 35(11):e4795. PubMed ID: 35775868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes.
    Stern MB; Braffman BH; Skolnick BE; Hurtig HI; Grossman RI
    Neurology; 1989 Nov; 39(11):1524-6. PubMed ID: 2812334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.
    Huddleston DE; Langley J; Sedlacik J; Boelmans K; Factor SA; Hu XP
    Hum Brain Mapp; 2017 May; 38(5):2627-2634. PubMed ID: 28240402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spin-lattice distribution MRI maps nigral pathology in progressive supranuclear palsy (PSP) during life: a pilot study.
    Hutchinson M; Raff U; Chaná P; Huete I
    PLoS One; 2014; 9(1):e85194. PubMed ID: 24489655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.
    Lee H; Lee MJ; Kim EJ; Huh GY; Lee JH; Cho H
    Sci Rep; 2021 Feb; 11(1):2950. PubMed ID: 33536537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism.
    Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K
    J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathology of the substantia nigra.
    Gibb WR
    Eur Neurol; 1991; 31 Suppl 1():48-59. PubMed ID: 1830274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
    Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
    Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI.
    Shinde S; Prasad S; Saboo Y; Kaushick R; Saini J; Pal PK; Ingalhalikar M
    Neuroimage Clin; 2019; 22():101748. PubMed ID: 30870733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.